Several studies have suggested that Gal-3 is an emerging biomarker linked to myocardial fibrosis, tissue remodeling, and heart failure development; it has also been shown to be associated with heart failure severity [11,12,13]. The gene discussed is LGALS3; the disease is heart failure.